-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
October 08, 2025 - Quantitative Synthesis II: Interactive Quiz
When To Select Observational Studies
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
When To Select Observational Studies Interactive Quiz
When should observational …
-
effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
January 01, 2013 - Slide 1
Sensitivity Analysis for Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Sensitivity Analysis for Observational Comparative Effectiveness Research
This slide set is based on a user guide titled Developing a Protocol for Observati…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - Layout 1
Background
Anemia (deficiency of red blood cells)
occurs in 13-78 percent of patients
undergoing treatment for solid tumors and
30-40 percent of patients treated for
lymphoma. Tumor type, treatment
regimen, and history of prior cancer
therapy influence the risk and severity of
anemia. For example, among pa…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
January 01, 2013 - Single-arm studies in comparative effectiveness reviews
Research White Paper
Role of Single Group Studies in Agency for Healthcare
Research and Quality Comparative Effectiveness
Reviews
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
August 01, 2012 - 1
Comparative Effectiveness Review
Number 73
Serum Free Light Chain Analysis for the
Diagnosis, Management, and Prognosis
of Plasma Cell Dyscrasias
Executive Summary
Background
Plasma cell dyscrasias (PCDs) are a group
of neoplastic disorders characterized by
the uninhibited expansion of a monoclonal
popula…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Combination Therapy Versus Intensification of Statin Monotherapy:
An Update.
Draft revi…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
July 01, 2009 - process of mapping has included identifying the variations on
data content and storage locations occurring
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Diabetes Mellitus
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 07: Diabetes Mellitus
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - CER #40:
Effectiveness and Safety of Antiepileptic Medications
in Patients with Epilepsy
Original release date:
December, 2011
Surveillance Report:
November, 2012
Key Findings:
- Contacted experts thought many conclusions for KQ1 to 4
do not make sufficiently clear that they are based on
insufficien…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - CER #40:
Effectiveness and Safety of Antiepileptic Medications
in Patients with Epilepsy
Original release date:
December, 2011
Surveillance Report:
November, 2012
Key Findings:
- Contacted experts thought many conclusions for KQ1 to 4
do not make sufficiently clear that they are based on
insufficien…
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - according to recent, phase II trial results.
6
The
F508del mutation is the most common CF mutation, occurring
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-3rdplace_tympanic.pdf
October 08, 2025 - Middle Ear Infections: What to Expect and Treatment Options
1
Middle Ear Infections:
What to Expect and Treatment Options
(1)
Authors: Nicola Archie BSN, MSN, FNP-c & Tara Jones BSN, MSN, FNP-c
Reviewed by: Richard F. Kuehne, MD, MPH
2
Provider
Normal Tympanic Me…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
October 08, 2025 - Assessing Applicability: Interactive Case Study Quiz
Assessing Applicability
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Assessing Applicability Interactive Quiz
Why might trials with run-in periods and …
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
October 08, 2025 - Assessing Applicability: Interactive Case Study Quiz
Assessing Applicability
Interactive Quiz
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Assessing Applicability Interactive Quiz
Why might trials with run-in periods and …
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - It is intended to mimic the function of GLP-1, a naturally occurring
hormone that stimulates release … other drugs such as metformin and/or sulfonylurea.
46
It mimics the function of GLP-1, a
naturally occurring … a feeling of fullness and satiety to reduce continued
intake of exogenous glucose.
46
Naturally occurring
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - 71
Abstract
This chapter provides an overview of considerations for the development of outcome measures
for observational comparative effectiveness research (CER) studies, describes implications of the
proposed outcomes for study design, and enumerates issues of bias that may arise in incorporating the
ascertainme…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
April 01, 2015 - 1
Comparative Effectiveness Review
Number 150
Decisional Dilemmas in Discontinuing
Prolonged Disease-Modifying Treatment for
Multiple Sclerosis
Executive Summary
Background
Multiple sclerosis (MS) is a variably
debilitating disease characterized by
demyelination (deterioration of the
protective myelin sheat…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
October 01, 2010 - Question 4, lines 36-40: "Major adverse events
associated with RFA are relatively uncommon, overall occurring … some period of continued AAD use early after
ablation may be desirable, both because some arrhythmias occurring
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
September 29, 2014 - process is recommended by current clinical practice guidelines and
actually should reflect what is occurring … are most associated with the mentioned harms, which also tend not to
account from non-medical use occurring … For these specific harms, just as an exception was made for
outcomes occurring before 1 year of opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
October 01, 2014 - Short-term is defined as outcomes occurring within 6
months; long-term is defined as outcomes occurring … Short-term is defined as outcomes occurring within 6 months; long-term is
defined as outcomes occurring … aripiprazole resulted in an effective treatment for TD, but it was only moderately effective on co-occurring